RADIOLABELLED GRPR-ANTAGONIST FOR USE AS THERAGNOSTIC
The present disclosure relates to gastrin-releasing peptide receptor (GRPR) targeting pharmaceuticals and their use in a theragnostic approach for selection and therapy of subjects with GRPR-expressing malignancies. In particular, the present disclosure relates to a pharmaceutical composition of a r...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French |
Published |
01.04.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!